Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Taysha Gene Therapies, Inc. - Common Stock (NQ: TSHA )

1.835 -0.015 (-0.81%)
Streaming Delayed Price Updated: 10:36 AM EST, Dec 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Taysha Gene Therapies, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Taysha Gene Therapies to Host Key Opinion Leader Webinar on TSHA-106 for the Treatment of Angelman Syndrome
From Taysha Gene Therapies, Inc.
Via Business Wire
Taysha Announces Exclusive Option from UTSW to License Worldwide Rights to Clinical-Stage AAV9 Gene Therapy Program for CLN7 Disease, a Research Collaboration with UTSW to Develop Next-Generation Construct for CLN7 and a Grant Award to Batten Hope
From Taysha Gene Therapies
Via Business Wire
Taysha Gene Therapies Receives Orphan Drug Designation from the European Commission for TSHA-101 for the Treatment of Infantile GM2 Gangliosidosis
From Taysha Gene Therapies, Inc.
Via Business Wire
Analyst Ratings For Taysha Gene Therapies
Taysha Gene Therapies (NASDAQ:TSHA) has observed the following analyst rat... 
Via Benzinga
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc... 
Via Benzinga
Taysha Gene Therapies to Participate in Upcoming October Investor Healthcare Conferences
From Taysha Gene Therapies, Inc.
Via Business Wire
Taysha Receives Orphan Drug Designation from the European Commission for TSHA-102 for the Treatment of Rett Syndrome
From Taysha Gene Therapies, Inc.
Via Business Wire
Taysha Gene Therapies Announces Publication of Positive Preclinical Data for TSHA-104 Demonstrating Therapeutic Potential in SURF1-associated Leigh Syndrome in Journal Molecular Therapy: Methods & Clinical Development
From Taysha Gene Therapies, Inc.
Via Business Wire
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc... 
Via Benzinga
Exposures COVID-19
What 8 Analyst Ratings Have To Say About Taysha Gene Therapies
Analysts have provided the following ratings for Taysha Gene Therapies (NASDAQ: 
Via Benzinga
Taysha Gene Therapies to Host Key Opinion Leader Webinar on TSHA-102 for the Treatment of Rett Syndrome
From Taysha Gene Therapies, Inc.
Via Business Wire
Taysha Gene Therapies to Participate in Upcoming September Investor Healthcare Conferences
From Taysha Gene Therapies, Inc.
Via Business Wire
Taysha's Rare Epilepsy Gene Therapy Receives European Orphan Drug Tag
The European Commission has granted Orphan Drug designation to Taysha Gene Therapies Inc's (NASDAQ: TSHA) TSHA-105, AAV9-based gene therapy for SLC13A5-... 
Via Benzinga
Taysha Gene Therapies Receives Orphan Drug Designation for TSHA-105 for the Treatment of Epilepsy Caused by SLC13A5 Deficiency From the European Commission
From Taysha Gene Therapies, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Aerpio Pharmaceuticals (NASDAQ:ARPO) stock increased by 25.72% to $2.59 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is... 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Tuesday morning, 282 companies set new 52-week lows. Key Facts: Alibaba Group Holding (NYSE:BABA) was the biggest company by market cap to set a new 52-week low.... 
Via Benzinga
Taysha Gene Therapies to Host Key Opinion Leader Webinar on TSHA-118 for the Treatment of CLN1 Disease
From Taysha Gene Therapies, Inc.
Via Business Wire
Taysha Gene Therapies, Inc. (TSHA) Q2 2021 Earnings Call Transcript
TSHA earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Taysha Gene Secures $100M In Debt Financing For Support Pipeline Development
Taysha Gene Therapies Inc (NASDAQ: TSHA) has entered into a loan and security agreement with Silicon Valley Bank (SVB), providing up to $100 million of... 
Via Benzinga
Taysha Gene Therapies Reports Second Quarter 2021 Financial Results and Provides Corporate Update
From Taysha Gene Therapies
Via Business Wire
Taysha Gene Therapies Secures up to $100 Million Non-Dilutive Term Loan Financing
From Taysha Gene Therapies, Inc.
Via Business Wire
Taysha Gene Therapies to Release Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 16
From Taysha Gene Therapies, Inc.
Via Business Wire
Taysha Gene Therapies to Participate in Upcoming August Investor Healthcare Conferences
From Taysha Gene Therapies, Inc.
Via Business Wire
Taysha Gene Therapies to Host Manufacturing Day
From Taysha Gene Therapies, Inc.
Via Business Wire
Earnings Scheduled For August 16, 2021
Companies Reporting Before The Bell • Entera Bio (NASDAQ:ENTX) is likely to report earnings for its second quarter. • Data Storage (NASDAQ:DTST) is expected to... 
Via Benzinga
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures Product Safety
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's morning session, 216 companies made new 52-week lows. Noteworthy Points: Alibaba Group Holding (NYSE:BABA) was the largest firm by market cap... 
Via Benzinga
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 16, 2021
Upgrades According to Citigroup, the prior rating for Alcoa Corp (NYSE: 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.